(RETRANS) ChemoTech’s Animal Care division signs Letter of Intent with a prominent player in the North American veterinary market
Retransmission of press release that was issued on 18 October 2022 at 23:55.
Scandinavian ChemoTech can gladly state that its subsidiary Vetiqure AB is close to securing a very impactful distribution agreement with Avante Animal Health in the United States.The Letter of Intent (LOI) clearly outlines a very detailed arrangement for a planned distribution agreement. It also specifies the aim to install approximately six vetIQure™ systems at various university hospitals and leading clinics, which are already clients of Avante Animal Health. These systems are to be installed at the end of